Medscape2d
Eye Toxicities Are a Growing Concern With Certain ADCs
Some antibody-drug conjugates may cause such significant ocular toxicity that patients have vision damage or have to stop ...
A Breakthrough in Gene Editing Offers Hope for a Cure for Cold Sores
A series of stories that looks at the breakthroughs, setbacks, and overall status of vaccines and cures for hard-to-treat ...
Ramstad: Anger and debate over health care will continue after Thompson’s alleged killer is jailed
The arrest in the slaying of UnitedHealthcare CEO Brian Thompson was the first step to putting his alleged killer behind bars ...
Cancellation of kids’ asthma medication continues to cause turmoil for Mass. families
Massachusetts families are still struggling to find alternatives almost a year after GlaxoSmithKline canceled a widely ...
Medscape4d
Lupus Nephritis Biomarkers ‘Robustly’ Predict Clinical Response, Long-Term Kidney Damage
With an accuracy of 86%, the biomarker panel has the potential to be clinically useful in diagnosis, management, and ...
Barclays Remains a Hold on GlaxoSmithKline (GSK)
Barclays analyst Emily Field maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £14.50. The ...
GlaxoSmithKline (GSK) Receives a Hold from Jefferies
Jefferies analyst Peter Welford maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today. The company’s shares opened today at ...
Peptide-Based Hematological Disorders Therapeutics Market To Grow At 8.1% CAGR, Reaching US$ 1,253.9 Million By 2034
Advances in peptide drug development and the rising prevalence of hematological disorders are driving demand for peptide-based therapeu ...
Future Market Insights9h
Blow Fill Seal Technology Market Poised to Surge to USD 5,258.5 Million by 2033, Driven by Pharmaceutical Industry Adoption
The blow fill seal technology market is expected to grow from its estimated USD 3,107.8 million in 2024 to USD 5,258.5 million in 2034. Between 2024 and 2034, sales are expected to increase at a ...
thorax.bmj1d
Pneumococcal pneumonia trends in adults hospitalised with community-acquired pneumonia over 10 years (2013–2023) and the role of serotype 3
Background With higher valency pneumococcal vaccines on the horizon and new adult immunisation strategies under discussion, ...
Time Is Up For Tempus AI With IPO Lockup Expiration
Tempus AI leverages AI for precision medicine, offering genomics, data services, and AI applications. Click here to read an ...
Medindia1d
Patient Centricity in Pharma: Best Practices for Building Trust
Discover top strategies for patient-centricity in pharma, fostering trust through personalized care, transparent communication, and patient engagement.